Transcatheter Aortic Valve Implantation (TAVI) gives broadly comparable results to conventional open surgery, with equal efficacy, faster recovery time and improved quality of life at one year, ...
Principal investigator Dr Craig Smith (Columbia University, New York, NY) presented the one-year results here at the American College of Cardiology 2011 Scientific Sessions/i2 Summit today. Those ...
NEW ORLEANS, LA—TAVI with a self-expanding, supra-annular valve has durable effects compared with SAVR for up to 3 years in patients with severe aortic stenosis and at low surgical risk, findings from ...
PARIS, France—A meta-analysis of landmark clinical trials comparing TAVI against surgical aortic valve replacement across the surgical-risk spectrum of patients with severe aortic stenosis showed ...
Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...
Among low-risk patients with severe, symptomatic aortic stenosis who are eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve replacement (SAVR), data are lacking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results